title: Functional genetic screening reveals the role of mitochondrial cytochrome b as a mediator of FAS-induced apoptosis.
abstract: Functional selection of genetic suppressor elements (GSEs), engineered gene fragments that interfere with the function of a particular gene product, was used to identify regulators of FAS-induced apoptosis. Chicken DF-1 cells expressing human FAS receptor and susceptible to FAS-induced apoptosis were infected with a GSE library consisting of randomly fragmented normalized chicken cDNAs in a replication-competent avian retroviral vector. Virus-producing cells were subjected to several rounds of selection using FAS agonistic antibodies, resulting in isolation of a set of GSEs conferring resistance to FAS-induced apoptosis. Surprisingly, one of the isolated GSEs encoded a 42 amino acid-long polypeptide derived from the C-terminal half of cytochrome b (Cyt b) encoded by the mitochondrial genome. Subsequent experiments showed that caspase 8-dependent cleavage of mitochondrial Cyt b and translocation of its C-terminal half into the cytoplasm occurred during FAS-induced apoptosis in both chicken and human cells. Ectopic cytoplasmic expression of either full-length Cyt b or its C-terminal half in several human cell lines induced apoptosis, which could be suppressed by the isolated GSE, but not by Bcl2 over-expression or Apaf-1 or cytochrome c knock-down. These results reveal a cytochrome c-independent branch of FAS-induced apoptosis involving cleavage and cytoplasmic release of mitochondrial Cyt b.
authors.affiliation: Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
authors.forename: Andrei P
authors.initials: AP
authors.lastname: Komarov
authors.forename: Oskar W
authors.initials: OW
authors.lastname: Rokhlin
authors.forename: Chang-An
authors.initials: CA
authors.lastname: Yu
authors.forename: Andrei V
authors.initials: AV
authors.lastname: Gudkov
mesh_terms: D000818:Animals; D017209:Apoptosis; D051023:BH3 Interacting Domain Death Agonist Protein / Q000378:metabolism; D053181:Caspase 8 / Q000378:metabolism; D002460:Cell Line; D002645:Chickens; D045303:Cytochromes b / Q000378:metabolism*; D045304:Cytochromes c / Q000378:metabolism; D003593:Cytoplasm / Q000378:metabolism; D006367:HeLa Cells; D006801:Humans; D008928:Mitochondria / Q000378:metabolism*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D013489:Suppression, Genetic; D019014:fas Receptor / Q000235:genetics / Q000378:metabolism*
chemical_list: D051023:BH3 Interacting Domain Death Agonist Protein; C491901:FAS protein, human; D019253:Proto-Oncogene Proteins c-bcl-2; D019014:fas Receptor; D045304:Cytochromes c; D045303:Cytochromes b; D053181:Caspase 8
references.citation: Nature. 1997 Apr 3;386(6624):517-21
references.pmid: 9087414
references.citation: Cell. 2000 Jul 7;102(1):43-53
references.pmid: 10929712
references.citation: J Virol. 1993 Apr;67(4):1811-6
references.pmid: 8383211
references.citation: J Biol Chem. 1994 Jan 21;269(3):2292-8
references.pmid: 8294488
references.citation: J Immunol. 2002 Oct 1;169(7):3726-35
references.pmid: 12244166
references.citation: Nature. 1998 Apr 16;392(6677):677-84
references.pmid: 9565029
references.citation: Nature. 1999 Feb 4;397(6718):441-6
references.pmid: 9989411
references.citation: Cell. 2002 Apr;109 Suppl:S97-107
references.pmid: 11983156
references.citation: Virology. 1984 Jul 15;136(1):89-99
references.pmid: 6330999
references.citation: Cell. 1997 May 2;89(3):413-24
references.pmid: 9150141
references.citation: Nucleic Acids Res. 1992 Feb 25;20(4):711-7
references.pmid: 1531871
references.citation: Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1172-6
references.pmid: 9037025
references.citation: Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3231-5
references.pmid: 8386368
references.citation: J Virol. 1998 Apr;72(4):3501-3
references.pmid: 9525691
references.citation: Science. 1997 Feb 21;275(5303):1132-6
references.pmid: 9027315
references.citation: Cell. 1997 Aug 8;90(3):405-13
references.pmid: 9267021
references.citation: Cell Death Differ. 2003 Jan;10(1):26-35
references.pmid: 12655293
references.citation: Science. 2001 Apr 27;292(5517):727-30
references.pmid: 11326099
references.citation: Science. 1998 Jul 3;281(5373):64-71
references.pmid: 9651245
references.citation: Nature. 1999 Aug 26;400(6747):886-91
references.pmid: 10476969
references.citation: EMBO J. 2002 Jul 15;21(14):3704-14
references.pmid: 12110583
references.citation: Mol Cell. 2003 Feb;11(2):529-41
references.pmid: 12620239
references.citation: Science. 2002 May 31;296(5573):1634-5
references.pmid: 12040173
references.citation: Oncogene. 2004 Apr 12;23(16):2861-74
references.pmid: 15077149
references.citation: Nature. 2001 Mar 29;410(6828):549-54
references.pmid: 11279485
references.citation: J Biol Chem. 1999 Jan 15;274(3):1541-8
references.pmid: 9880531
references.citation: Cancer Cell. 2002 Feb;1(1):19-30
references.pmid: 12086884
references.citation: Cancer Res. 2003 Nov 1;63(21):7475-82
references.pmid: 14612548
references.citation: Nature. 1997 Jul 10;388(6638):190-5
references.pmid: 9217161
references.citation: Cancer Res. 1995 Sep 15;55(18):4023-8
references.pmid: 7664275
references.citation: EMBO J. 2003 Aug 15;22(16):4132-42
references.pmid: 12912912
references.citation: Science. 2002 May 31;296(5573):1635-6
references.pmid: 12040174
references.citation: J Virol. 2000 Apr;74(8):3572-78
references.pmid: 10729132
references.citation: Science. 1998 Aug 28;281(5381):1305-8
references.pmid: 9721089
references.citation: Curr Biol. 2000 Jun 1;10(11):640-8
references.pmid: 10837247
references.citation: Science. 1997 Jul 4;277(5322):60-6
references.pmid: 9204897
references.citation: Int Immunol. 1998 Jan;10(1):85-90
references.pmid: 9488158
references.citation: Nature. 2000 Oct 12;407(6805):789-95
references.pmid: 11048730
references.citation: Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3744-8
references.pmid: 8170981